1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts. Issue 2 (December 2016) Authors: Althammer, Sonja; Steele, Keith; Rebelatto, Marlon; Tan, Tze; Wiestler, Tobias; Schmidt, Guenter; Higgs, Brandon; Li, Xia; Shi, Li; Jin, Xiaoping; Antal, Joyce; Gupta, Ashok; Ranade, Koustubh; Binning, Gerd; Bellmunt, Joaquim; de Wit, Ronald; Vaughn, David; Fradet, Yves; Lee, Jae; Fong, Lawrence Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 2(2016) Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts. Issue 2 (December 2016) Authors: Althammer, Sonja; Steele, Keith; Rebelatto, Marlon; Tan, Tze; Wiestler, Tobias; Schmidt, Guenter; Higgs, Brandon; Li, Xia; Shi, Li; Jin, Xiaoping; Antal, Joyce; Gupta, Ashok; Ranade, Koustubh; Binning, Gerd; Bellmunt, Joaquim; de Wit, Ronald; Vaughn, David; Fradet, Yves; Lee, Jae; Fong, Lawrence Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 2(2016) Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 343 Phase 3 study of pembrolizumab + docetaxel and prednisone/prednisolone for metastatic castration-resistant prostate cancer (mCRPC) pretreated with next-generation hormonal agents (NHAs) (KEYNOTE-921). (10th December 2020) Authors: Petrylak, Daniel; Shore, Neal; Bennamoun, Mostefa; Ratta, Raffaele; Piulats, Josep; Li, Ben; Schloss, Charles; Fizazi, Karim Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 343 Phase 3 study of pembrolizumab + docetaxel and prednisone/prednisolone for metastatic castration-resistant prostate cancer (mCRPC) pretreated with next-generation hormonal agents (NHAs) (KEYNOTE-921). (9th November 2020) Authors: Petrylak, Daniel; Shore, Neal; Bennamoun, Mostefa; Ratta, Raffaele; Piulats, Josep; Li, Ben; Schloss, Charles; Fizazi, Karim Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A368 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immune response from STRIDE, a randomized, Phase II, open-label study of sipuleucel-T (sip-T) with concurrent vs sequential enzalutamide (enz) administration in metastatic castration-resistant prostate cancer (mCRPC). Issue 2 (December 2015) Authors: Drake, Charles; Quinn, David; Dreicer, Robert; Antonarakis, Emmanuel; Shore, Neal; Corman, John; Concepcion, Raoul; Pieczonka, Christopher; Campogan, Dwayne; Fan, Li-Qun; Chang, Nancy; Sheikh, Nadeem; Petrylak, Daniel Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Immune response from STRIDE, a randomized, Phase II, open-label study of sipuleucel-T (sip-T) with concurrent vs sequential enzalutamide (enz) administration in metastatic castration-resistant prostate cancer (mCRPC). (4th November 2015) Authors: Drake, Charles G; Quinn, David; Dreicer, Robert; Antonarakis, Emmanuel; Shore, Neal; Corman, John; Concepcion, Raoul; Pieczonka, Christopher; Campogan, Dwayne; Fan, Li-Qun; Chang, Nancy; Sheikh, Nadeem; Petrylak, Daniel Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The 2nd meeting of the Campania Society of Oncology Immunotherapy (SCITO): focus on hepatocellular carcinoma, kidney and bladder cancer. Issue 1 (19th January 2016) Authors: Daniele, Bruno; Sangro, Bruno; Petrylak, Daniel; Calabrò, Fabio; Cartenì, Giacomo; Montesarchio, Vincenzo; De Placido, Sabino; Ascierto, Paolo A. Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The 2nd meeting of the Campania Society of Oncology Immunotherapy (SCITO): focus on hepatocellular carcinoma, kidney and bladder cancer. Issue 1 (December 2016) Authors: Daniele, Bruno; Sangro, Bruno; Petrylak, Daniel; Calabrò, Fabio; Cartenì, Giacomo; Montesarchio, Vincenzo; De Placido, Sabino; Ascierto, Paolo Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗